Glucose monitor study for hospital patients pulled before start
NCT ID NCT06329297
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if continuous glucose monitors (CGMs) work accurately in hospital patients, including those in intensive care after open-heart surgery. Researchers planned to compare CGM readings with standard finger-stick blood glucose tests. However, the study was withdrawn before any participants were enrolled, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Continuous glucose monitor (CGM) device
- What this could lead to
- If successful, this could show that continuous glucose monitors are reliable in hospital settings, potentially improving glucose management for patients.
- What could go wrong
- This trial was withdrawn before enrolling any participants, so no results are available. The approach may still face challenges like accuracy issues or practical barriers in intensive care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERGLYCEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a breath test replace finger pricks for diabetes?
- Could a wearable sensor replace fingerstick checks for sepsis patients in the ICU?
- Could a simple sugar help people with type 1 diabetes exercise safely?
- New diabetes program helps hill tribe elders control blood sugar
- Your personality might predict your lab results
- Gene link to ICU blood sugar problems found